Characteristics of Patients With Spondyloarthritis Followed in Rheumatology Units in Spain. emAR II Study

Casals-Sánchez, J.L.; Prous, María Jesús García de Yébenes y; Descalzo, Miguel Ángel; Olmos, Juan Manuel Barrio; Ortells, Loreto Carmona; García, César

doi:10.1016/j.reumae.2012.04.010

Cited by 20 publications

(10 citation statements)

References 22 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…En la cohorte reclutada, la espondilitis anquilosante fue la EsA de entrada al estudio más frecuente (55,1%), seguida de la artritis psoriásica (25,1%) y la espondiloartritis indiferenciada (16,1%). La distribución fue prácticamente idéntica a la del estudio emAR II, también realizado en consultas hospitalarias de Reumatología, en el que el 55,2% fueron pacientes con espondilitis anquilosante, el 22,2% artritis psoriásica y el 16,1% espondiloartritis indiferenciada 15 , por lo que esta cohorte parece reflejar el perfil de pacientes vistos en la práctica clínica habitual en consultas hospitalarias de Reumatología.…”

Section: Discussionunclassified

Manifestaciones extraarticulares en pacientes con espondiloartritis. Características basales de la cohorte de pacientes con espondiloartritis del estudio AQUILES

Zarco

González-Fernández

Serna

et al. 2015

Reumatología Clínica

View full text Add to dashboard Cite

Section: Discussionunclassified

Manifestaciones extraarticulares en pacientes con espondiloartritis. Características basales de la cohorte de pacientes con espondiloartritis del estudio AQUILES

Zarco

González-Fernández

Serna

et al. 2015

Reumatología Clínica

View full text Add to dashboard Cite

“…The data provided in the analysis of the result of the self-assessments show that some of the problems identified in recent multinational reports [ 4 , 7 ] are also identified in Spain. In view of these results, care integrated by interdisciplinary teams has not been implemented, the implementation of practice guidelines requires greater effort and monitoring of patients over time is highly variable.…”

Section: Discussionmentioning

confidence: 86%

“…The conclusions of this group indicated variable care across health systems, which may result in progression of the disease does not stop, there is a gradual reduction in function, an increase in disability and a poor quality of life of the patients. For example, in Spain it has been observed that around 60% of the medical records did not quantify the joint involvement and in 87% there was no composite joint index and 84% did not have a measure of function [ 4 , 5 ].…”

Section: Introductionmentioning

confidence: 99%

Evaluating standards of care in psoriatic arthritis of the QUANTUM project (qualitative initiative to improve outcomes): results of an accreditation project in Spain

et al. 2020

View full text Add to dashboard Cite

In Spain, the QUANTUM project has been promoted to reduce variability in clinical practice and improve the care and quality of life of people with psoriatic arthritis (PsA) by accrediting PsA units throughout the Spanish national health system. To present the results of this approach which sought to ensure an optimum level of quality for patients with PsA. Descriptive analysis of the self-assessments that the PsA units have carried out assessing their degree of compliance with the quality standards established in the QUANTUM project grouped into four blocks: shortening time to diagnosis; optimizing disease management; improving multidisciplinary collaboration; and improving patient monitoring. A total of 41 PsA units were self-evaluated. They met 64.1% of the defined quality standards. Optimize disease management obtained a higher level of standards compliance (72%) and improve multidisciplinary collaboration the lesser (63.9%). Accessibility to the treatments available for PsA in all hospitals was guaranteed (100%). Appropriate diagnostic equipment is available (97.6%). Compliance with specific quality standards leads to detect actions that should be implemented: quality of life assessment (9.8%), locomotor system assessment (12.2%), physical examination data record (14.6%), periodic cardiovascular risk assessment (17.1%). The QUANTUM project results make it possible to visualise how to care for patients with PsA is being developed in Spain. Problems identified in recent multinational reports are also identified in Spain.

show abstract

“…This situation may be explained by including genetic factors and geographic differences in lifestyles and eating behaviors. In emAR study from another Mediterranean country, Spain, the most common conditions were reported as hypertension (17.4%), peptic ulcer (6.8%) and diabetes mellitus (6.1%) [17]. In a study which was conducted in United Kingdom, prevalence of overall comorbidities was reported as 50%.…”

Section: Discussionmentioning

confidence: 98%

“…In REGISPONSER study conducted on 1,385 Spanish patients with AS, frequency of peripheral involvement was found as 17.4% [21]. In emAR study, peripheral arthritis was reported in 54.8% of the patients [17]. They explained this high percentage by the dominance of psoriatic arthritis or undifferentiated spondyloarthritis in their series.…”

Section: Impact Of Age Gender and Bmi On Comorbiditiesmentioning

confidence: 93%

Comorbidity profiles among patients with ankylosing spondylitis

Garip¹,

Eser²,

Güler³

et al. 2016

MMJ

View full text Add to dashboard Cite

Objectives:We aimed to evaluate comorbidities and their association with clinical parameters in patients with ankylosing spondylitis (AS). Patients and Methods:A hundred and ten AS patients were included. Disease activity was evaluated by Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), functional status by Bath Ankylosing Spondylitis Functional Index (BASFI), spinal mobility Bath Ankylosing Spondylitis Metrology Index (BASMI) and quality of life by Nottingham Health Profile (NHP).Results: Comorbidities were detected in 28.18% of the patients. These were peptic ulcer (20.91%), hypertension (20%), lung disease (15.45%), diabetes mellitus (13.64%), osteoporosis (10.91%), ischemic heart disease (10%), renal diseases (Ig A nephropathy and renal papillary necrosis, 1.82%) and cancers (papillary thyroid carcinoma and renal cell ca, 1.82%), respectively. Patients with comorbidities scored significantly higher in BASDAI, BASMI, BASFI, VAS-pain, and pain, physical mobility, and energy subgroups of NHP (p<0.05). Peripheral involvement was observed in 27.27% of the patients. The frequency of comorbidities was higher in the patients with peripheral involvement (Pearson X 2 =54.725, p<0.01). Conclusion:Comorbid conditions of AS are associated with more active disease, functional impairment and deterioration in quality of life. Therefore, comorbidities should be detected and treated earlier in order to reduce their negative impact on disease outcome.

show abstract

Characteristics of Patients With Spondyloarthritis Followed in Rheumatology Units in Spain. emAR II Study

Cited by 20 publications

References 22 publications

Manifestaciones extraarticulares en pacientes con espondiloartritis. Características basales de la cohorte de pacientes con espondiloartritis del estudio AQUILES

Manifestaciones extraarticulares en pacientes con espondiloartritis. Características basales de la cohorte de pacientes con espondiloartritis del estudio AQUILES

Evaluating standards of care in psoriatic arthritis of the QUANTUM project (qualitative initiative to improve outcomes): results of an accreditation project in Spain

Comorbidity profiles among patients with ankylosing spondylitis

Contact Info

Product

Resources

About